Ovid Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Ovid Therapeutics Inc
CIK #0001636651
EDGAR Form CIK 2011 - 2026
10-K [0001636651]
10-Q [0001636651]
3 [0001636651]
4 [0001636651]
8-K [0001636651]
D [0001636651]
SC 13D [0001636651]
SC 13G [0001636651]
Form 13D/13G Filer Form 13D/13G Subject Filed
Sirenia Capital Management LP OVID Therapeutics Inc [2026-05-15]
Balyasny Asset Management LP OVID Therapeutics Inc [2026-05-15]
Eventide Asset Management LLC OVID Therapeutics Inc [2026-05-15]
ADAR1 Capital Management LLC OVID Therapeutics Inc [2026-02-17]
Federated Hermes Inc OVID Therapeutics Inc [2026-01-08]
Point72 Asset Management LP OVID Therapeutics Inc [2026-01-05]
Affinity Asset Advisors LLC OVID Therapeutics Inc [2025-12-18]
RA Capital Management LP OVID Therapeutics Inc [2025-12-18]
Janus Henderson Group PLC OVID Therapeutics Inc [2025-12-08]
BlackRock Inc OVID Therapeutics Inc [2024-01-29]
View All
Form 3/4/5 Subject 2011 - 2026
Carter Charles Ross
Ovid Therapeutics Inc
Greka Anna
Papadopoulos Stelios
Fitzgerald Kevin Joseph
Friedman Bart
Levin Jeremy M
Alexander Margaret A
Bernstein Karen
Rona Jeffrey A
Duncan Barbara Gayle
Takeda Pharmaceuticals USA Inc
Takeda Pharmaceutical Co Ltd
Perone Thomas Michael
Tardio Jason
Poole Robert Michael
Rakhit Amit
Williams Douglas E
Haasner Dirk
Daly Timothy
Millennium Pharmaceuticals Inc
During Matthew
Ward Ana
Werber Yaron
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Ovid Therapeutics Inc OVID
Series A Warrant (right to buy) · derivative
2026-03-23 Option exercise 47,333 $0.00
Ovid Therapeutics Inc OVID
Common Stock
2026-03-23 Option exercise 47,333 $1.40 66,266
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
2026-02-26 Grant 65,000 $0.00
Ovid Therapeutics Inc OVID
Common Stock
2026-02-26 Grant 68,125 $0.00
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
2026-02-26 Grant 65,000 $0.00
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
2026-02-26 Grant 65,000 $0.00
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
2026-02-26 Grant 408,750 $0.00
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
2026-02-26 Grant 1,435,000 $0.00
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
2026-02-26 Grant 957,000 $0.00
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
2026-02-26 Grant 65,000 $0.00
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
2026-02-26 Grant 65,000 $0.00
Ovid Therapeutics Inc OVID
Common Stock
2026-02-23 Sell 11,656 $1.45 16,901
Ovid Therapeutics Inc OVID
Common Stock
2026-02-23 Sell 8,541 $1.45 12,384
Ovid Therapeutics Inc OVID
Employee Stock Option (right to buy) · derivative
2026-01-04 Grant 890,000 $0.00
Ovid Therapeutics Inc OVID
Common Stock
2025-12-15 Conversion 71,000
Ovid Therapeutics Inc OVID
Series B Convertible Preferred Stock · derivative
2025-12-15 Conversion 71 $0.00
Ovid Therapeutics Inc OVID
Series B Convertible Preferred Stock · derivative
2025-12-11 Buy 71
Ovid Therapeutics Inc OVID
Series A Warrant (right to buy) · derivative
2025-12-11 Buy 47,333
Ovid Therapeutics Inc OVID
Series B Warrant (right to buy) · derivative
2025-12-11 Buy 35,500
Ovid Therapeutics Inc OVID
Common Stock
2025-12-08 Conversion 1,250,000 $0.00
showing 20 of 180 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com